Colorifix
Norwich
About Colorifix
Colorifix is a biotechnology company that has pioneered the first entirely biological process to produce, deposit and fix pigments onto textiles. Using a synthetic biology approach, it offers a radically different solution to incumbent dyeing technologies that entirely cuts out the use of harsh chemistry and leads to huge reductions in water consumption. Colorifix’s investors include Cambridge Enterprise, H&M, Mills Fabrica, Primera Impact and Sagana, whose collective backing is funding its expansion. For more information, visit www.colorifix.com
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $49.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2025)
- Website: colorifix.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Commercial, Fashion
Social Profiles
Canonical: https://fsome.com/organization/colorifix-78974 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.